Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

[Nitrates and coronary vascular endothelium dysfunction]

A Berdeaux¹, J L Dubois-Randé, L Hittinger

¹Département de Pharmacologie, Faculté de Médecine Paris Sud, le Kremlin Bicêtre, France.

Annales De Cardiologie Et D'Angeiologie

|July 1, 1997

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Pentraxin 3 in primary percutaneous coronary intervention for ST elevation myocardial infarction is associated with early irreversible myocardial damage : Kinetic profile, relationship to interleukin 6 and infarct size.

European heart journal. Acute cardiovascular care·2020

Same author

Direct myocardial implantation of human embryonic stem cells in a dog model of Duchenne cardiomyopathy reveals poor cell survival in dystrophic tissue.

Journal of stem cells & regenerative medicine·2014

Same author

The cardioprotectant 3',4'-dihydroxyflavonol inhibits opening of the mitochondrial permeability transition pore after myocardial ischemia and reperfusion in rats.

Pharmacological research·2014

Same author

Ultrafast and whole-body cooling with total liquid ventilation induces favorable neurological and cardiac outcomes after cardiac arrest in rabbits.

Circulation·2011

Same author

Inhibition of mitochondrial membrane permeability as a putative pharmacological target for cardioprotection.

Current medicinal chemistry·2009

Same author

Emergency treatment of obstructive sleep apnea: a new option in the treatment of a refractory acute heart failure episode.

Sleep medicine·2007

The vascular endothelium regulates blood flow and clotting. Endothelial dysfunction, common in cardiovascular diseases, impairs these functions, but exogenous nitric oxide (NO) can restore vasomotor and antiaggregant activity.

Area of Science:

Cardiovascular Physiology
Endothelial Biology
Pharmacology

Context:

The vascular endothelium is crucial for regulating hemostasis and vasomotor activity.
It interfaces between blood and vascular smooth muscle, releasing endothelium-derived relaxing factors (EDRFs) like nitric oxide (NO) and prostacyclin (PGI2).
Endothelial dysfunction, seen in hypertension, heart failure, atherosclerosis, and diabetes, impairs EDRF synthesis and increases oxidative catabolism.

Purpose:

To highlight the role of the endothelium in vascular homeostasis.
To explain the consequences of endothelial dysfunction on hemostasis and vasomotor activity.
To discuss the therapeutic potential of exogenous NO in managing endothelial dysfunction.

Summary:

Endothelial cells release EDRFs (NO, PGI2) in response to stimuli, regulating blood flow and preventing thrombosis.

Related Experiment Videos

Absence or dysfunction of the endothelium leads to impaired EDRF production and increased oxidative stress, causing hemostatic and vasomotor disorders.

Exogenous NO donors and nitrates offer an effective, endothelium-independent treatment for these vascular dysfunctions.

Impact:

Understanding endothelial function is critical for diagnosing and treating cardiovascular diseases.
Exogenous NO administration provides a therapeutic strategy for conditions characterized by endothelial dysfunction.
This research underscores the importance of NO in maintaining vascular health and offers insights into novel treatment approaches.